ArticlemAbs
Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
Diane E Milenic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
pooled itcites it